Nisa Investment Advisors Portfolio holdings
AUM
$22.2B
1-Year Return
21.03%
This Quarter Return
-2.76%
1 Year Return
+21.03%
3 Year Return
+95.61%
5 Year Return
+159.15%
10 Year Return
+382.87%
AUM
$20B
AUM Growth
-$5.79B
(-22%)
Cap. Flow
-$4.75B
Cap. Flow
% of AUM
-23.74%
Top 10 Holdings %
Top 10 Hldgs %
40.52%
Holding
3,132
New
125
Increased
1,114
Reduced
1,306
Closed
151
Top Buys
| 1 |
Qualcomm
QCOM
|
+$40.3M |
| 2 |
AT&T
T
|
+$40M |
| 3 |
Electronic Arts
EA
|
+$28.4M |
| 4 |
Equinix
EQIX
|
+$25.3M |
| 5 |
Applied Materials
AMAT
|
+$17.7M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.85B |
| 2 |
NVIDIA
NVDA
|
+$144M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$109M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$92.3M |
| 5 |
Microsoft
MSFT
|
+$56.1M |
Sector Composition
| 1 | Technology | 23.66% |
| 2 | Financials | 11.62% |
| 3 | Healthcare | 8.63% |
| 4 | Communication Services | 7.47% |
| 5 | Consumer Discretionary | 7.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Definitive Healthcare
DH
$432M
| $19.1K | ﹤0.01% |
6,600
-380
| -5% | -$1.1K |
|
1902
First Bancorp
FNLC
$301M
| $19K | ﹤0.01% |
+769
| New | +$19K |
|
1903
Sally Beauty Holdings
SBH
$1.48B
| $19K | ﹤0.01% |
2,100
+850
| +68% | +$7.68K |
|
1904
Ardelyx
ARDX
$1.59B
| $19K | ﹤0.01% |
3,862
+1,054
| +38% | +$5.18K |
|
1905
Virtus Investment Partners
VRTS
$1.34B
| $19K | ﹤0.01% |
110
| – | – |
|
1906
PagerDuty
PD
$1.53B
| $18.9K | ﹤0.01% |
1,035
-151
| -13% | -$2.76K |
|
1907
Brookdale Senior Living
BKD
$1.78B
| $18.9K | ﹤0.01% |
3,014
+432
| +17% | +$2.7K |
|
1908
Employers Holdings
EIG
$983M
| $18.8K | ﹤0.01% |
371
| – | – |
|
1909
Stock Yards Bancorp
SYBT
$2.27B
| $18.7K | ﹤0.01% |
270
+245
| +980% | +$17K |
|
1910
Simmons First National
SFNC
$2.96B
| $18.6K | ﹤0.01% |
898
-32
| -3% | -$664 |
|
1911
Westlake Corp
WLK
$11.3B
| $18.6K | ﹤0.01% |
186
| – | – |
|
1912
Cable One
CABO
$968M
| $18.6K | ﹤0.01% |
70
-192
| -73% | -$51K |
|
1913
National Bankshares
NKSH
$192M
| $18.5K | ﹤0.01% |
695
+673
| +3,059% | +$17.9K |
|
1914
Foghorn Therapeutics
FHTX
$293M
| $18.5K | ﹤0.01% |
5,057
-30
| -0.6% | -$109 |
|
1915
Organogenesis Holdings
ORGO
$625M
| $18.4K | ﹤0.01% |
4,264
+106
| +3% | +$458 |
|
1916
Stoke Therapeutics
STOK
$1.29B
| $18.4K | ﹤0.01% |
2,760
+56
| +2% | +$372 |
|
|
LOAN
1917
Manhattan Bridge Capital
LOAN
$61.3M
| $18.3K | ﹤0.01% |
3,096
| – | – |
|
1918
Vicor
VICR
$2.28B
| $18.3K | ﹤0.01% |
391
+4
| +1% | +$187 |
|
1919
Astronics
ATRO
$1.41B
| $18.2K | ﹤0.01% |
755
+130
| +21% | +$3.14K |
|
1920
Perimeter Solutions
PRM
$3.26B
| $18.2K | ﹤0.01% |
1,809
+1,352
| +296% | +$13.6K |
|
1921
Anavex Life Sciences
AVXL
$805M
| $18.2K | ﹤0.01% |
2,123
-138
| -6% | -$1.18K |
|
1922
Amplitude
AMPL
$1.47B
| $18.1K | ﹤0.01% |
1,780
+93
| +6% | +$948 |
|
1923
Beam Therapeutics
BEAM
$2.08B
| $18K | ﹤0.01% |
923
-114
| -11% | -$2.23K |
|
1924
Skyward Specialty Insurance
SKWD
$1.87B
| $18K | ﹤0.01% |
340
+330
| +3,300% | +$17.5K |
|
1925
Limoneira
LMNR
$276M
| $18K | ﹤0.01% |
1,010
-10
| -1% | -$178 |
|